Nearly 80% of these breast tumors demonstrated promoter methylation (122), and the heterozygous and homozygous allelic loss of ARID1A occurred in 35.2 and 2% of cases, respectively, in breast cancer (151). Here, ARID1A is linked to breast carcinoma.